Goldman Sachs Group Inc Journey Medical Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.92 - $5.47 $58,297 - $109,208
19,965 New
19,965 $73,000
Q2 2022

Aug 15, 2022
SELL
$2.62 - $5.06 $28,626 - $55,285
-10,926 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.93 - $5.76 $97,833 - $143,389
-24,894 Reduced 69.5%
10,926 $53,000
Q4 2021

Feb 14, 2022
BUY
$5.17 - $9.9 $185,189 - $354,618
35,820 New
35,820 $193,000

Others Institutions Holding DERM

# of Institutions
39
Shares Held
2.93M
Call Options Held
0
Put Options Held
0
View Full List

About Journey Medical Corp

DERM Quotes by TradingView
  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $44.1M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email